Chinese consulate attack ‘mastermind’ being treated at New Delhi hospital

Sources say Aslam alias Achu is a BLA commander


News Desk November 23, 2018
Sources say Aslam alias Achu is a BLA commander. PHOTO: EXPRESS

Mastermind of today's terrorist attack on Chinese consulate in Karachi that resulted in martyrdom of two policemen is currently receiving medical treatment at a hospital in New Delhi.

Aslam alias Achu is a commander of proscribed Balochistan Liberation Army (BLA), who is being treated at Max Hospital in the Indian capital, sources told Express News on Friday.

They said Achu had fled after getting injured in an encounter with the Pakistani security forces 18 months ago. Several members of BLA were killed in the shootout, they added.

Photos of the BLA commander hospitalised in the New Delhi hospital have gone viral on social media after today’s incident in Karachi.

Attack on Chinese consulate foiled; two policemen martyred

The terrorist attempt was foiled by security forces and all staff members of the foreign mission were reported safe in today’s attack.

Two policemen were martyred in an exchange of fire with the terrorists. All three attackers were also killed in the ensuing gunfight with security forces.

DIG Karachi South Javeed Alam Odho elaborated that a terrorist with suicide vest was gunned down by security forces and the other two were also killed in the ensuing gunfight. A female police officer, SSP Suhai Talpur, led the operation against the terrorists.

A suicide jacket, arms and ammunition were recovered from the attackers.

COMMENTS (5)

Asim | 5 years ago | Reply This is so unfortunate ... time for both countries leadership to show maturity and help resolve the differences and save human lives and work for the prosperity by being friends and not enemies.
Muhammad Qayyum Abro | 5 years ago | Reply Pakistan should ask UN to handover the terrorist leader.
VIEW MORE COMMENTS
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ